5-Bromo-1H-pyrrolo[2,3-b]pyridin-2-one

Catalog No.: 
ACTVZI425
CAS No.: 
183208-34-6
Molecular Formula: 
C7H5BrN2O
Molecular Weight: 
213.03
5-Bromo-1H-pyrrolo[2,3-b]pyridin-2-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g97%$56.00In stockInquiry
10g97%$95.00In stockInquiry
25g97%$225.00In stockInquiry
100g97%$874.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Bromo-1H-pyrrolo[2,3-b]pyridin-2-one
IUPAC Name5-bromo-1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one
MDL No.MFCD07367221
Molecular FormulaC7H5BrN2O
Molecular Weight213.03
SMILESO=C1CC2=CC(Br)=CN=C2N1
InChI KeyDHPKTHROZFIEJK-UHFFFAOYSA-N
Synonym5-bromo-1,3-dihydro-2H-pyrrolo[2,3-b]-pyridin-2-one | 5-bromo-1,3-dihydro-2H-pyrrolo[2,3-b]-pyridin2-one | 5-bromo-1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one | AM20050898 | 5-bromo-1H-pyrrolo[2,3-b]pyridin-2(3H)-one | CS-B0502 | 5-bromo-7-azaoxindole | FT
CAS No.183208-34-6
PubChem CID15504062

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACTVZI425 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACUGLC362 route compound structure diagram
    ACUGLC362149142-67-6In Stock
  2. Then
  3. ACTVZI425 route product structure diagram
    ACTVZI425183208-34-6In Stock
Inquiry

2. ACTVZI425 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTVZI425 route product structure diagram
    ACTVZI425183208-34-6In Stock
Inquiry

3. ACTVZI425 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTVZI425 route product structure diagram
    ACTVZI425183208-34-6In Stock
Inquiry

Comments (0)